Biomarker Profiling in Abdominal Aortic Aneurysm Patients

NCT03703947 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 440

Last updated 2024-07-16

No results posted yet for this study

Summary

The BIOMArCS-AAA study aims to investigate the associations of (temporal patterns of) blood biomarkers with aneurysm growth in patients with abdominal aortic aneurysm (AAA), with particular attention to biomarkers that have demonstrated prognostic value for adverse disease outcomes in coronary artery disease and biomarkers for the main genetic pathways associated with AAA.

Conditions

  • Abdominal Aortic Aneurysm

Sponsors & Collaborators

Principal Investigators

  • Isabella Kardys, MD, PhD · Erasmus Medical Center

  • Eric Boersma, MSc, PhD · Erasmus Medical Center

  • Hence JM Verhagen, MD, PhD · Erasmus Medical Center

  • Bram Fioole, MD, PhD · Maasstad Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-23
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03703947 on ClinicalTrials.gov